Free Trial

Evoke (LON:EVOK) Shares Down 18.7% - Here's What Happened

Evoke logo with Consumer Cyclical background
Remove Ads

Evoke plc (LON:EVOK - Get Free Report) shares fell 18.7% during trading on Wednesday . The company traded as low as GBX 56 ($0.72) and last traded at GBX 58.05 ($0.75). 55,595,465 shares were traded during trading, an increase of 1,853% from the average session volume of 2,847,325 shares. The stock had previously closed at GBX 71.40 ($0.92).

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on EVOK. Berenberg Bank cut their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating on the stock in a research report on Wednesday, December 4th. Jefferies Financial Group reissued a "buy" rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th.

Get Our Latest Stock Report on EVOK

Evoke Stock Performance

The stock has a market cap of £224.78 million, a P/E ratio of -1.26 and a beta of 0.84. The firm has a 50-day moving average price of GBX 68.88 and a 200-day moving average price of GBX 63.49.

Evoke (LON:EVOK - Get Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, research analysts predict that Evoke plc will post 12.7648305 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Andrea Gisle Joosen bought 14,572 shares of the firm's stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Corporate insiders own 27.00% of the company's stock.

Evoke Company Profile

(Get Free Report)

Featured Articles

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads